Here, our data suggest that METTL3-mediated m6A RNA modification is positively associated with the increase in MDSC expansion and affects tumour development and prognosis in CC and induces CD33 + cells to differentiate into MDSCs in the tumour microenvironment. The gene discussed is CD33; the disease is neoplasm.